Normal Range of Superior Mesenteric Artery in Young Chinese Population and Its Correlation With Retroperitoneal Adipose Tissue

May 17, 2022 updated by: Professor Winnie W.C. Chu, Chinese University of Hong Kong

Normal Range of Superior Mesenteric Artery on Computerized Tomography in Young Chinese Population and Its Correlation With Retroperitoneal Adipose Tissue

In literature, superior mesenteric artery (SMA) angle, also named as aortomesenteric angle (AMA), varies greatly in both adult and children; while the aortomesenteric distance also ranges widely. Both AMA and AMD are influenced by retroperitoneal fat. Decrease of AMA and AMD may lead to the superior mesenteric artery syndrome(SMAS), which is a rare medical condition mainly presenting with duodenum obstruction. To our knowledge, normal range of AMA and AMD in local young Chinese population remain unclear; on the other hand, there have only a few studies exploring the relationship between them. This project proposes to establish the normal range of AMA and AMD in local young Chinese population, and to further investigate how the retroperitoneal adipose tissue correlates with AMA and AMD. The normal range obtained in this proposed study will provide more specific reference value to distinguish abnormal AMA and AMD, and to improve the diagnosis accuracy of SMAS in local population. Moreover, this study will provide deeper insight concerning the impact of retroperitoneal fat on AMA and AMD.

Study Overview

Study Type

Observational

Enrollment (Actual)

510

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hong Kong, China
        • Department of Radiology, North District Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The investigators will retrospectively recruit individuals from the local population who had undergone abdomen contrast CT scans within hospitals in the New Territories East Cluster (NTEC) of Hong Kong for both emergency and elective purposes in the year 2013-2019. Total sample will comprise two groups: (1) Non-SMAS Group (N=500); and (2) SMAS group (N=10).

Description

Inclusion Criteria:

  • With age range of 10-35 years old.
  • Chinese ethnicity.
  • With abdomen contrast CT.

Exclusion Criteria:

  • Any patients with diagnosis of SMAS will be excluded from the Non-SMAS group.
  • Patients who had undergone more than one CT scan during the research period.
  • Previous retroperitoneal, abdominal surgery.
  • Conditions causing significant weight loss, e.g. anorexia nervosa, malabsorption.
  • Presence of abdominal masses or pathology that will affect the anatomy of aorta- superior mesenteric artery and the retroperitoneal structures.
  • Presence of severe scoliosis and/or history of spinal fixation that may increase incidence of SMA syndrome.
  • Presence of free intraperitoneal or retroperitoneal fluid that may affect fat measurement, e.g. following trauma, or ascites.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Non-SMAS group
subjects in this group are not clinically diagnosed as superior mesenteric artery syndrome(SMAS).
abdomen contrast computerized tomography performed for both emergency and elective purposes in HK public hospitals.
SMAS group
subjects in this group are clinically diagnosed as superior mesenteric artery syndrome(SMAS).
abdomen contrast computerized tomography performed for both emergency and elective purposes in HK public hospitals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
aortomesenteric angle (AMA)
Time Frame: 2 years
aortomesenteric angle in degree measured on sagittal CT image
2 years
aortomesenteric distance (AMD)
Time Frame: 2 years
aortomesenteric distance in millimeter(mm) on axial CT image
2 years
visceral fat area
Time Frame: 2 years
visceral fat area in square centimeter(cm2) evaluated by image post-processing software
2 years
subcutaneous fat area
Time Frame: 2 years
subcutaneous fat area in square centimeter(cm2) evaluated by image post-processing software
2 years
area ratio of visceral fat to subcutaneous fat
Time Frame: 2 years
area ratio in percentage(%)
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kai Ho Yam, MBChB, Department of Radiology, North District Hospital, Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2019

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

May 2, 2019

First Submitted That Met QC Criteria

May 2, 2019

First Posted (Actual)

May 3, 2019

Study Record Updates

Last Update Posted (Actual)

May 19, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aortomesenteric Angle

Clinical Trials on computerized tomography

Subscribe